
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra® in India as a second brand of Wegovy®".
Filed with NSE ·

Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra® in India as a second brand of Wegovy®".
6ix hasn’t read this filing yet.
Emcure Pharmaceuticals Limited on 6ix
Follow Emcure Pharmaceuticals into a list and get an email when it puts out news.
Follow Emcure Pharmaceuticals